Page last updated: 2024-08-26

lysophosphatidic acid and B16 Melanoma

lysophosphatidic acid has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, XY; Chen, J; Fan, JQ; Li, ZY; Ren, JH; Wu, G; Xia, Y; Zhang, LL; Zhang, RG; Zhu, F	1
Jalink, K; Jongsma, M; Matas-Rico, E; Moolenaar, WH; Rzadkowski, A	1

Other Studies

2 other study(ies) available for lysophosphatidic acid and B16 Melanoma

Article	Year
Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo. Molecular cancer therapeutics, 2015, Volume: 14, Issue:7 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lysophospholipids; Male; Melanoma, Experimental; Mice, Inbred C57BL; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Tumor Burden	2015
LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. PloS one, 2011, Volume: 6, Issue:12 Topics: alpha-MSH; Animals; Cell Membrane; Cell Polarity; Cell Proliferation; Chemotaxis; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; HeLa Cells; Humans; Lysophospholipids; Melanoma, Experimental; Mice; Phosphatidylinositol Phosphates; Phosphoric Diester Hydrolases; Polylysine; Receptors, Lysophosphatidic Acid; Serum; Sphingosine; Subcellular Fractions; Transfection	2011

Article

Year

Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:7

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lysophospholipids; Male; Melanoma, Experimental; Mice, Inbred C57BL; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Tumor Burden

2015

LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor.

PloS one, 2011, Volume: 6, Issue:12

Topics: alpha-MSH; Animals; Cell Membrane; Cell Polarity; Cell Proliferation; Chemotaxis; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; HeLa Cells; Humans; Lysophospholipids; Melanoma, Experimental; Mice; Phosphatidylinositol Phosphates; Phosphoric Diester Hydrolases; Polylysine; Receptors, Lysophosphatidic Acid; Serum; Sphingosine; Subcellular Fractions; Transfection

2011